Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
720
NCT01464905
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 31, 2011
Completion: Dec 31, 2014
NCT01732198
A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers
Phase: Phase 2
Start: Mar 31, 2013
Completion: Apr 30, 2014